Jules Bordet Institute

Brussels B-1000

0 studies enrolling now · 9 studies all time

What they study most

Brain Metastases, Breast Cancer, Cancer, Candidemia, Cholangiocarcinoma, Intrahepatic, Fungal Infection, Fungemia, Hepatocellular Carcinoma, Invasive Candidiasis, Lung Cancer, Malignant Glioma, Melanoma

Studies at this site

• Effects of JNJ-53718678 in Adult and Adolescent Participants Who Had a Hematopoietic Stem Cell Transplantation and Who Are Infected With Respiratory Syncytial Virus (RSV) — Stopped early
• Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer — Completed
• Bortezomib, Selinexor, and Dexamethasone in Patients With Multiple Myeloma — Completed
• Selinexor Treatment of Refractory Myeloma — Completed
• Study of GNS561 in Patients With Liver Cancer — Stopped early
• CD101 Compared to Caspofungin Followed by Oral Step Down in Subjects With Candidemia and/or Invasive Candidiasis-Bridging Extension — Completed
• Efficacy, Safety and Tolerability of AG013 in Oral Mucositis Compared to Placebo When Administered Three Times Per Day — Stopped early
• An Open-label, Phase I/IIa, Dose Escalating Study of 2B3-101 in Patients With Solid Tumors and Brain Metastases or Recurrent Malignant Glioma. — Completed
• A Study of Sativex® for Pain Relief in Patients With Advanced Malignancy. — Completed